Chris Lau
All posts from Chris Lau
Chris Lau in Value Stocks,

So What, If Synergy Pharmaceuticals Misses

Expectations Synergy Pharmceuticals (SGYP) would report $0.20 per share in losses were high, but the company missed by $0.03/sh. So what? Hints the company would sell the company mattered more. Given the stock is up 20% in the last month, investors are not at all worried.

In the press release, Synergy mentioned launching its drug without any partners. Plecanatide and Dolc are big products.

Looking ahead, if SGYP is looking to sell its product on its own, it will need to sell shares, diluting shareholders slightly.

Short-term pain for all the gain.

Further reading: